{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:21:56Z","timestamp":1790166116820,"version":"4.1.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11,1]]},"DOI":"10.1093\/infdis\/jix314","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T11:09:44Z","timestamp":1504177784000},"page":"834-841","source":"Crossref","is-referenced-by-count":33,"title":["Replication and Excretion of the Live Attenuated Tetravalent Dengue Vaccine CYD-TDV in a Flavivirus-Naive Adult Population: Assessment of Vaccine Viremia and Virus Shedding"],"prefix":"10.1093","volume":"216","author":[{"given":"Joseph","family":"Torresi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C","family":"Richmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon G","family":"Heron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Marjason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Starr-Spires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"van der Vliet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T Anh","family":"Wartel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Bouckenooghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,9,14]]},"reference":[{"key":"key\n\t\t\t\t20171101120526_CIT0001","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","article-title":"Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial","volume":"384","author":"CYD14 Study Group","year":"2014","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171101120526_CIT0002","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1411037","article-title":"Efficacy of a tetravalent dengue vaccine in children in Latin America","volume":"372","author":"CYD15 Study Group","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171101120526_CIT0003","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and long-term safety of a dengue vaccine in regions of endemic disease","volume":"373","author":"CYD-TDV Dengue Vaccine Working Group","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171101120526_CIT0004","volume-title":"Guideline on environmental risk assessments for medicinal products consisting of, or containing, genetically modified organisms (GMO)","author":"European Medicines Agency","year":"2006"},{"key":"key\n\t\t\t\t20171101120526_CIT0005","volume-title":"ICH considerations\u2014general principles to address virus and vector shedding","author":"European Medicines Agency","year":"2009"},{"key":"key\n\t\t\t\t20171101120526_CIT0006","volume-title":"Guideline on quality, non-clinical and clinical aspects of live recombinant viral vectored vaccines","author":"European Medicines Agency","year":"2010"},{"key":"key\n\t\t\t\t20171101120526_CIT0007","volume-title":"Guidelines for the clinical evaluation of dengue vaccines in endemic areas","author":"World Health Organization","year":"2008"},{"key":"key\n\t\t\t\t20171101120526_CIT0008","volume-title":"Guidelines on the quality, safety and efficacy of dengue tetravalent vaccines (live, attenuated). WHO Technical Report Series. No. 979","author":"World Health Organization","year":"2013"},{"key":"key\n\t\t\t\t20171101120526_CIT0009","doi-asserted-by":"crossref","first-page":"e1309","DOI":"10.1371\/journal.pntd.0001309","article-title":"Kinetics of viremia and NS1 antigenemia are shaped by immune status and virus serotype in adults with dengue","volume":"5","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20171101120526_CIT0010","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/315215","article-title":"Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity","volume":"181","year":"2000","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171101120526_CIT0011","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/649916","article-title":"A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults","volume":"201","year":"2010","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171101120526_CIT0012","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1016\/j.vaccine.2011.03.057","article-title":"Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: randomized controlled phase I trial in the Philippines","volume":"29","year":"2011","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20171101120526_CIT0013","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1097\/INF.0b013e3181fe05af","article-title":"Live-attenuated tetravalent dengue vaccine in dengue-na\u00efve children, adolescents, and adults in mexico city: randomized controlled phase 1 trial of safety and immunogenicity","volume":"30","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20171101120526_CIT0014","doi-asserted-by":"crossref","first-page":"724","DOI":"10.4269\/ajtmh.2011.10-0436","article-title":"Priming effect of dengue and yellow fever vaccination on the immunogenicity, infectivity, and safety of a tetravalent dengue vaccine in humans","volume":"85","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20171101120526_CIT0015","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1016\/j.vaccine.2013.08.088","article-title":"Safety and immunogenicity of three tetravalent dengue vaccine formulations in healthy adults in the USA","volume":"31","year":"2013","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20171101120526_CIT0016","author":"World Health Organization","year":"2006"},{"key":"key\n\t\t\t\t20171101120526_CIT0017","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.4161\/21645515.2014.972131","article-title":"Assessment of bivalent and tetravalent dengue vaccine formulations in flavivirus-na\u00efve adults in Mexico","volume":"10","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"key\n\t\t\t\t20171101120526_CIT0018","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1097\/INF.0000000000000752","article-title":"First experience of concomitant vaccination against dengue and MMR in toddlers","volume":"34","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20171101120526_CIT0019","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/INF.0000000000001542","article-title":"Immunogenicity and safety of a booster injection of DTaP-IPV\/\/Hib (Pentaxim\u00ae) administered concomitantly with tetravalent dengue vaccine in healthy toddlers aged 15 to 18 months in Mexico: a randomized trial","volume":"36","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20171101120526_CIT0020","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.4161\/hv.25562","article-title":"Persistence of Th1\/Tc1 responses one year after tetravalent dengue vaccination in adults and adolescents in Singapore","volume":"9","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"key\n\t\t\t\t20171101120526_CIT0021","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.1016\/j.vaccine.2008.08.019","article-title":"Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects","volume":"26","year":"2008","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20171101120526_CIT0022","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1016\/j.vaccine.2015.08.008","article-title":"Lot-to-lot consistency of a tetravalent dengue vaccine in healthy adults in Australia: a randomised study","volume":"33","year":"2015","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20171101120526_CIT0023","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jviromet.2008.03.026","article-title":"Standardized quantitative RT-PCR assays for quantitation of yellow fever and chimeric yellow fever-dengue vaccines","volume":"151","year":"2008","journal-title":"J Virol Methods"},{"key":"key\n\t\t\t\t20171101120526_CIT0024","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.1016\/j.vaccine.2012.07.043","article-title":"Immunogenicity and safety of tetravalent dengue vaccine in 2\u201311 year-olds previously vaccinated against yellow fever: randomized, controlled, phase II study in Piura, Peru","volume":"30","year":"2012","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20171101120526_CIT0025","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4269\/ajtmh.2009.80.302","article-title":"Evaluation of interferences between dengue vaccine serotypes in a monkey model","volume":"80","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20171101120526_CIT0026","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/infdis\/jir279","article-title":"Interference and facilitation between dengue serotypes in a tetravalent live dengue virus vaccine candidate","volume":"204","year":"2011","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171101120526_CIT0027","first-page":"623","article-title":"Viraemia in patients with naturally acquired dengue infection","volume":"59","year":"1981","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t20171101120526_CIT0028","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1128\/JCM.01775-10","article-title":"Detection of yellow fever 17D genome in urine","volume":"49","year":"2011","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171101120526_CIT0029","doi-asserted-by":"crossref","first-page":"986","DOI":"10.4269\/ajtmh.2006.75.986","article-title":"Growth characteristics of ChimeriVax-Den vaccine viruses in Aedes aegypti and Aedes albopictus from Thailand","volume":"75","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20171101120526_CIT0030","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/vim.2008.0007","article-title":"Guidelines for plaque-reduction neutralization testing of human antibodies to dengue viruses","volume":"21","year":"2008","journal-title":"Viral Immunol"},{"key":"key\n\t\t\t\t20171101120526_CIT0031","doi-asserted-by":"crossref","first-page":"962","DOI":"10.4269\/ajtmh.12-0461","article-title":"Optimization and validation of a plaque reduction neutralization test for the detection of neutralizing antibodies to four serotypes of dengue virus used in support of dengue vaccine development","volume":"88","year":"2013","journal-title":"Am J Trop Med Hyg"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/216\/7\/834\/21498550\/jix314.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T00:14:12Z","timestamp":1570061652000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jid\/article\/216\/7\/834\/4158083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,14]]},"references-count":31,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,9,14]]},"published-print":{"date-parts":[[2017,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jix314","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,10,1]]},"published":{"date-parts":[[2017,9,14]]}}}